Literature DB >> 2487545

Effects of long-term nicardipine treatment on hemodynamics of large arteries in essential hypertension.

E Arosio1, P Pancera, G Arcaro, F Priante, G Montesi, M Zannoni, A Lechi.   

Abstract

The effects of the calcium-entry blocker nicardipine on brachial hemodynamics were studied in 22 patients (18 male, 4 female) with essential hypertension, who were treated with 20 mg tid for 1 year. Compliance, characteristic impedance, vascular resistances, and tangential tension were measured before treatment and after 1, 3, and 12 months of treatment by an automatic recording from a B-mode, high-resolution, real-time scanner and pulsed Doppler velocimetry for the calculation of the flow volume. We observed statistically significant variations in compliance and impedance after 1 month (3.21 +/- 0.59 dyn-1 cm4 10(-7) vs. 1.26 +/- 0.16 dyn-1 cm4 10(-7) and 50.6 +/- 4.7 dyn s cm-510(2) vs. 91.4 +/- 7.3 dyn s cm-5 10(2), respectively; mean +/- SEM; p less than 0.001), while tangential tension was significantly reduced after only 3 months (23.2 +/- 2.2 mmHg vs. 25.4 +/- 2.3 mmHg cm; p less than 0.05). The correlation between variations in mean blood pressure and in the hemodynamic parameters studied remained statistically significant throughout the study. Nicardipine improved the parameters of large-artery hemodynamics that favor a normal systolic pulse.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2487545     DOI: 10.1007/bf01869568

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  19 in total

Review 1.  Pharmacological basis for use of calcium channel antagonists in hypertension.

Authors:  A Scriabine; S Kazda; B Garthoff; P A Nickerson
Journal:  Angiology       Date:  1988-01       Impact factor: 3.619

Review 2.  The fourth Sir George Pickering memorial lecture. The structure of the resistance vasculature in essential hypertension.

Authors:  M J Mulvany
Journal:  J Hypertens       Date:  1987-04       Impact factor: 4.844

3.  Systemic and arterial hemodynamic effects of nifedipine (20 mg) in mild-to-moderate hypertension.

Authors:  J A Levenson; M E Safar; A C Simon; J A Boutier; L Griener
Journal:  Hypertension       Date:  1983 Nov-Dec       Impact factor: 10.190

4.  Peripheral large arteries and the response to antihypertensive treatment.

Authors:  M E Safar; J A Bouthier; J A Levenson; A C Simon
Journal:  Hypertension       Date:  1983 Sep-Oct       Impact factor: 10.190

5.  The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension.

Authors:  J Levenson; A C Simon; J Bouthier; B C Maarek; M E Safar
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

6.  Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertension.

Authors:  H O Ventura; F H Messerli; W Oigman; F G Dunn; E Reisin; E D Frohlich
Journal:  Am J Cardiol       Date:  1983-03-01       Impact factor: 2.778

7.  Aortic pulse wave velocity, elasticity, and composition in a nonhuman primate model of atherosclerosis.

Authors:  D J Farrar; H D Green; M G Bond; W D Wagner; R A Gobbeé
Journal:  Circ Res       Date:  1978-07       Impact factor: 17.367

8.  An indirect approach for the study of the elastic modulus of the brachial artery in patients with essential hypertension.

Authors:  M E Safar; G M London; R G Asmar; C J Hugues; S A Laurent
Journal:  Cardiovasc Res       Date:  1986-08       Impact factor: 10.787

9.  Forearm arterial compliance: a new measure of arterial compliance?

Authors:  D H Fitchett
Journal:  Cardiovasc Res       Date:  1984-11       Impact factor: 10.787

10.  Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy, and hyperplasia.

Authors:  G K Owens; S M Schwartz
Journal:  Circ Res       Date:  1982-09       Impact factor: 17.367

View more
  3 in total

1.  Amlodipine and haemodynamic effects of cyclo-oxygenase inhibition.

Authors:  P Minuz; P Pancera; M Ribul; F Priante; M Degan; A Campedelli; E Arosio; A Lechi
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

Review 2.  Nicardipine. A review of its pharmacology and therapeutic efficacy in older patients.

Authors:  J E Frampton; D Faulds
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

3.  Changes in the haemodynamics of large arteries induced by single doses of nicardipine, enalapril, atenolol and urapidil.

Authors:  P Pancera; E Arosio; F Priante; M Ribul; M Zannoni; G Talamini; A Lechi
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.